Evidence map›Paper›PMID 16846526›Full record

ArticleArthritis research & therapy2006

Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis.

Ann W Morgan, Jim I Robinson, Jennifer H Barrett, Javier Martin, Amy Walker, Sarah J Babbage, William E R Ollier, Miguel A Gonzalez-Gay, John D Isaacs

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06865274 (Multicenter Prospective Interventional Study to Evaluate the Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Myelin Oligodendrocyte Glycoprotein Antibody Disease, and Multiple Sclerosis.), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06865274 narecruitingnot on this mapstarted 2025, after this paper: background citation

Multicenter Prospective Interventional Study to Evaluate the Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Myelin Oligodendrocyte Glycoprotein Antibody Disease, and Multiple Sclerosis.

TypeinterventionalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2025 to 2027Enrolled50ConditionsNeuromyelitis Optica Spectrum Disorders, MOGAD, Multiple SclerosisArmsBlood draw for the laboratory assessment
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Takayasu's disease effects on the kidneys: current perspectives.International journal of nephrology and renovascular disease · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Human FcR polymorphism and disease.Current topics in microbiology and immunology · 2014
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2010
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Ann W MorganLeeds Institute for Molecular Medicine, University of Leeds, Leeds, UK. a.w.morgan@leeds.ac.uk
Jim I Robinson
Jennifer H Barrett
Javier Martin
Amy Walker
Sarah J Babbage
William E R Ollier
Miguel A Gonzalez-Gay
John D Isaacs
University of Leeds · GBHospital Xeral Calde · ESInstituto de Parasitología y Biomedicina "López - Neyra" · ESNewcastle University · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Fc gamma receptors have been shown to play important roles in the initiation and regulation of many immunological and inflammatory processes and to amplify and refine the immune response to an infection. We have investigated the hypothesis that polymorphism within the FCGR genetic locus is associated with giant cell arteritis (GCA). Biallelic polymorphisms in FCGR2A, FCGR3A, FCGR3B and FCGR2B were examined for association with biopsy-proven GCA (n = 85) and healthy ethnically matched controls (n = 132) in a well-characterised cohort from Lugo, Spain. Haplotype frequencies and linkage disequilibrium (D') were estimated across the FCGR locus and a model-free analysis performed to determine association with GCA. There was a significant association between FCGR2A-131RR homozygosity (odds ratio (OR) 2.10, 95% confidence interval (CI) 1.12 to 3.77, P = 0.02, compared with all others) and carriage of FCGR3A-158F (OR 3.09, 95% CI 1.10 to 8.64, P = 0.03, compared with non-carriers) with susceptibility to GCA. FCGR haplotypes were examined to refine the extent of the association. The haplotype showing the strongest association with GCA susceptibility was the FCGR2A-FCGR3A 131R-158F haplotype (OR 2.84, P = 0.01 for homozygotes compared with all others). There was evidence of a multiplicative joint effect between homozygosity for FCGR2A-131R and HLA-DRB1*04 positivity, consistent with both of these two genetic factors contributing to the risk of disease. The risk of GCA in HLA-DRB1*04 positive individuals homozygous for the FCGR2A-131R allele is increased almost six-fold compared with those with other FCGR2A genotypes who are HLA-DRB1*04 negative. We have demonstrated that FCGR2A may contribute to the 'susceptibility' of GCA in this Spanish population. The increased association observed with a FCGR2A-FCGR3A haplotype suggests the presence of additional genetic polymorphisms in linkage disequilibrium with this haplotype that may contribute to disease susceptibility. These findings may ultimately provide new insights into disease pathogenesis.

Indexed as

Genetic Predisposition to DiseaseHaplotypesAllelesAntigens, CDChromosome MappingGenotypeGiant Cell ArteritisGPI-Linked ProteinsHeterozygoteHLA-DR AntigensHLA-DRB1 ChainsHomozygoteHumansLinkage DisequilibriumPolymorphism, GeneticReceptors, IgGAntigens, CDFCGR2A protein, humanFCGR2B protein, humanFCGR3A protein, humanFCGR3B protein, humanGPI-Linked ProteinsHLA-DR AntigensHLA-DRB1 ChainsReceptors, IgG

Identifiers

PMID16846526
PMCPMC1779375
OpenAlexW1587015226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.